PLRX
PLIANT THERAPEUTICS, INC.
+0.05 (+4.67%)1.12USD194K成交股數69.4M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | 0 | 0-100% | 0 | 0 | 0 | 248K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 16.7M | 13.6M | 15.6M | 17.9M | 32.2M | 43.4M | 47.8M | 45.6M | 37.1M | 33.2M | 32.3M | 33.0M |
| 銷售管理費用 | 7.1M | 8.2M | 8.0M | 10.3M | 13.4M | 15.5M | 14.3M | 15.0M | 15.2M | 13.9M | 15.3M | 14.6M |
| 營業利益 | −23.9M-48% | −21.8M-63% | −23.6M-62% | −28.3M-53% | −45.6M-13% | −58.9M+25% | −62.0M+30% | −60.6M+28% | −52.4M | −47.0M | −47.7M | −47.3M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | -19,083.9% |
| 稅後淨利 | −22.4M-48% | −20.0M-64% | 275M-576% | −26.3M-53% | −43.3M-8% | −56.2M-120% | −57.8M+39% | −55.9M+36% | −47.0M | 282M | −41.5M | −41.2M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | -16,609.7% |
| 稀釋 EPS | -0.36-49% | -0.32-65% | -0.37-61% | -0.43-53% | -0.71-9% | -0.92+35% | -0.95+36% | -0.92+31% | -0.78 | -0.68 | -0.70 | -0.70 |
| 稀釋股數 | 61.9M | 61.8M | 61.4M | 61.4M | 61.4M | 61.2M | 60.7M | 60.4M | 60.2M | 58.7M | 59.7M | 59.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 24.9M | 22.2M | 45.4M | 93.7M | 86.8M | 91.9M | 79.6M | 80.4M | 114M | 63.2M | 57.7M | 55.0M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | 0 | 0 | 1.6M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 190M | 203M | 225M | 277M | 300M | 345M | 446M | 484M | 522M | 512M | 540M | 575M |
| 有息負債 | 0 | 0 | 0 | 30.4M | 30.4M | 30.3M | 30.1M | 30.1M | 30.0M | 10.1M | 10.0M | 10.0M |
| 總負債 | 43.0M | 37.4M | 44.0M | 76.3M | 79.7M | 87.6M | 99.8M | 91.1M | 84.3M | 38.6M | 37.4M | 41.8M |
| 股東權益 | 147M | 165M | 181M | 200M | 220M | 257M | 346M | 393M | 437M | 474M | 503M | 533M |
| 負債比 | 22.6% | 18.5% | 19.5% | 27.6% | 26.6% | 25.4% | 22.4% | 18.8% | 16.2% | 7.5% | 6.9% | 7.3% |
| 淨現金(現金 − 有息負債) | 24.9M | 22.2M | 45.4M | 63.3M | 56.5M | 61.7M | 49.5M | 50.3M | 84.3M | 53.2M | 47.7M | 45.0M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −19.2M-61% | – | – | – | −48.9M | – | – | −30.3M | – | – | – |
| 資本支出 | – | 0 | – | – | – | 262K | – | – | 1.5M | – | – | – |
| 自由現金流 | – | −19.2M-61% | – | – | – | −49.1M | – | – | −31.8M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0 | – | 149M | –% | -2.43 | −129M |
| FY2024 | 0 | -100.0% | 210M | –% | -3.47 | −159M |
| FY2023 | 1.6M | -83.7% | 161M | 10,208.9% | -2.75 | −117M |
| FY2022 | 9.7M | +27.9% | −123M | -1,273.3% | -2.94 | −96.4M |
| FY2021 | 7.6M | -81.9% | −97.3M | -1,284.5% | -2.71 | −77.4M |
| FY2020 | 41.8M | -26.7% | −41.5M | -99.3% | -1.95 | −38.8M |
| FY2019 | 57.1M | – | −631K | -1.1% | -4.22 | −3.7M |